Discussion in 'Parents of Children with Type 1' started by Nicole N, Jan 28, 2016.
Many good points are made in this article.
But pharmaceutical companies sometimes don't "play fair". Take, for example, the way Sanofi recently screwed Mannkind's Afrezza over with their, IMO, premeditated lack of marketing in order to keep their profit-generating injected insulin at the top of the heap.
Separate names with a comma.